These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 381269)

  • 1. PS-5, a new beta-lactam antibiotic. III. Synergistic effects and inhibitory activity against a beta-lactamase.
    Okamura K; Sakamoto M; Fukagawa Y; Ishikura T; Lein J
    J Antibiot (Tokyo); 1979 Apr; 32(4):280-6. PubMed ID: 381269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PS-5 inhibition of a beta-lactamase from Proteus vulgaris.
    Okamura K; Sakamoto M; Ishikura T
    J Antibiot (Tokyo); 1980 Mar; 33(3):293-302. PubMed ID: 6991465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of SF-2103A, a novel carbapenem antibiotic, as a beta-lactamase inhibitor.
    Niwa T; Yoshida T; Tamura A; Kazuno Y; Inouye S; Ito T; Kojima M
    J Antibiot (Tokyo); 1986 Jul; 39(7):943-55. PubMed ID: 3019978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stigmasterol: An adjuvant for beta lactam antibiotics against beta-lactamase positive clinical isolates.
    Yenn TW; Arslan Khan M; Amiera Syuhada N; Chean Ring L; Ibrahim D; Tan WN
    Steroids; 2017 Dec; 128():68-71. PubMed ID: 29104098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial and beta-lactamase inhibitory activities of carpetimycins A and B, new carbapenem antibiotics.
    Kobayashi F; Saino Y; Koshi T; Hattori Y; Nakayama M; Iwasaki A; Mori T; Mitsuhashi S
    Antimicrob Agents Chemother; 1982 Apr; 21(4):536-44. PubMed ID: 6979308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal beta-lactamase expression and resistance to beta-lactam antibiotics in Proteus vulgaris and Morganella morganii.
    Yang YJ; Livermore DM
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1385-91. PubMed ID: 3058021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-lactamase inhibitory activities and synergistic effects of 5,6-cis-carbapenem antibiotics.
    Okonogi K; Harada S; Shinagawa S; Imada A; Kuno M
    J Antibiot (Tokyo); 1982 Aug; 35(8):963-71. PubMed ID: 6982889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined antibacterial activity of amoxicillin with clavulanic acid against ampicillin-resistant strains.
    Matsuura M; Nakazawa H; Hashimoto T; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 Jun; 17(6):908-11. PubMed ID: 6967713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enterobacteria, beta-lactam antibiotics and beta-lactamases in clinical practice.
    Newsom SW; Marshall MJ; Harris AM
    J Med Microbiol; 1974 Nov; 7(4):473-82. PubMed ID: 4615152
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative antibacterial properties in vitro of seven olivanic acid derivatives: MM 4550, MM 13902, MM 17880, MM 22380, MM 22381, MM 22382 and MM 22383.
    Basker MJ; Boon RJ; Hunter PA
    J Antibiot (Tokyo); 1980 Aug; 33(8):878-84. PubMed ID: 6968745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sulfone beta-lactam compound which acts as a beta-lactamase inhibitor.
    Aswapokee N; Neu HC
    J Antibiot (Tokyo); 1978 Dec; 31(12):1238-44. PubMed ID: 310815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergism of PS-5 with penicillins and cephalosporins in antimicrobial activity against beta-lactam-resistant gram-negative microorganisms.
    Sakamoto M; Ishikura T; Fukagawa Y
    J Antibiot (Tokyo); 1984 Nov; 37(11):1414-22. PubMed ID: 6334679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Resistance of clinical strains of Proteus to various beta-lactam antibiotics].
    Shvidenko IG
    Antibiotiki; 1976 Oct; 21(10):910-4. PubMed ID: 793508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PS-5, a new beta-lactam antibiotic. II. Antimicrobial activity.
    Sakamoto M; Iguchi H; Okamura K; Hori S; Fukagawa Y; Ishikura T; Lein J
    J Antibiot (Tokyo); 1979 Apr; 32(4):272-9. PubMed ID: 38238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical antibacterial activities of beta-lactams against Proteus vulgaris: mechanism of the paradoxical effect.
    Ikeda Y; Nishino T
    Antimicrob Agents Chemother; 1988 Jul; 32(7):1073-7. PubMed ID: 3056246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of beta-lactamase of Bacillus licheniformis 749/C by compound PS-5, a new beta-lactam antibiotic.
    Fukagawa Y; Takei T; Ishikura T
    Biochem J; 1980 Jan; 185(1):177-85. PubMed ID: 6246876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nocardicin A, a new monocyclic beta-lactam antibiotic III. In vitro evaluation.
    Nishida M; Mine Y; Nonoyama S; Kojo H
    J Antibiot (Tokyo); 1977 Nov; 30(11):917-25. PubMed ID: 412823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental design and modelling approach to evaluate efficacy of β-lactam/β-lactamase inhibitor combinations.
    Sy SKB; Derendorf H
    Clin Microbiol Infect; 2018 Jul; 24(7):707-715. PubMed ID: 28760708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clavulanic acid, a novel inhibitor of beta-lactamases.
    Neu HC; Fu KP
    Antimicrob Agents Chemother; 1978 Nov; 14(5):650-5. PubMed ID: 310279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
    Yoshida T; Tateda E; Hiramatsu K; Yokota T
    Jpn J Antibiot; 1996 Apr; 49(4):324-37. PubMed ID: 8786624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.